Literature DB >> 6950959

Computed tomography of the liver and kidneys in glycogen storage disease.

J L Doppman, M Cornblath, A J Dwyer, A J Adams, M E Girton, J Sidbury.   

Abstract

Glycogen, in concentrations encountered in von Gierke's disease, has computed tomography (CT) attenuation coefficients in the 50 to 70 Hounsfield unit (HU: 1,000 scale) range and accounts for the increased density of the liver. However, in eight patients with Type I glycogen storage disease, simultaneous hepatic infiltration with fat and glycogen led to a range of liver CT densities from 13 to 80 HU. Fatty infiltration may facilitate the demonstration of hepatic tumors in older patients with this disease. Half the patients showed increased attenuation coefficients of the renal cortex, indicating glycogen deposition in the kidneys.

Entities:  

Mesh:

Year:  1982        PMID: 6950959     DOI: 10.1097/00004728-198202000-00009

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  10 in total

1.  Glycogen-rich clear cell carcinoma of the breast: a case report.

Authors:  Yuji Mizukami; Teruhiko Takayama; Akihiro Takemura; Katsuhiro Ichikawa; Masahisa Onoguchi; Takao Taniya
Journal:  J Med Ultrason (2001)       Date:  2009-03-14       Impact factor: 1.314

2.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

3.  Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse.

Authors:  Nathan S Artz; Catherine D G Hines; Stephen T Brunner; Rashmi M Agni; Jens-Peter Kühn; Alejandro Roldan-Alzate; Guang-Hong Chen; Scott B Reeder
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

Review 4.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

5.  Increased CT density of the liver due to cis-diaminedichloro platinum (II).

Authors:  T Aihara; M Fujioka; K Yamamoto
Journal:  Pediatr Radiol       Date:  1987

Review 6.  Current status of imaging in nonalcoholic fatty liver disease.

Authors:  Qian Li; Manish Dhyani; Joseph R Grajo; Claude Sirlin; Anthony E Samir
Journal:  World J Hepatol       Date:  2018-08-27

7.  Hepatocellular Glycogen Accumulation in the Setting of Poorly Controlled Type 1 Diabetes Mellitus: Case Report and Review of the Literature.

Authors:  Atinuke Aluko; Ikponmwosa Enofe; Jacob Burch; Julie Yam; Nazia Khan
Journal:  Case Reports Hepatol       Date:  2020-02-17

8.  A Case of Glycogenic Hepatopathy as a Complication of Poorly Controlled Type 1 Diabetes Mellitus.

Authors:  Samhitha Munugoti; Vamsee Reddy; Gaurav Patel; Maneesh Gaddam; Triveni Abburi
Journal:  Case Rep Endocrinol       Date:  2022-09-29

Review 9.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

10.  Fatty liver formation in fulminant type 1 diabetes

Authors:  Takashi Matsuo; Yoshihiko Ushiroda
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.